ES2007544A6 - Pharmaceutical products for promoting wound healing - Google Patents

Pharmaceutical products for promoting wound healing

Info

Publication number
ES2007544A6
ES2007544A6 ES8802427A ES8802427A ES2007544A6 ES 2007544 A6 ES2007544 A6 ES 2007544A6 ES 8802427 A ES8802427 A ES 8802427A ES 8802427 A ES8802427 A ES 8802427A ES 2007544 A6 ES2007544 A6 ES 2007544A6
Authority
ES
Spain
Prior art keywords
wound healing
pharmaceutical products
promoting wound
carrier
active ingredient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES8802427A
Other languages
Spanish (es)
Inventor
Janos Balini
Sandor Jancso
Tamas Farago
Janos Erdei
Istvan Kovacs
Nacida Harsy Zsuzsanna Emri
Nacida Lokodi Katalin Horvath
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Teva Pharmaceutical Works PLC
Original Assignee
Biogal Gyogyszergyar Rt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biogal Gyogyszergyar Rt filed Critical Biogal Gyogyszergyar Rt
Publication of ES2007544A6 publication Critical patent/ES2007544A6/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/0066—Medicaments; Biocides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/425—Porous materials, e.g. foams or sponges
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/44—Medicaments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/432—Inhibitors, antagonists
    • A61L2300/436—Inhibitors, antagonists of receptors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/80—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special chemical form
    • A61L2300/802—Additives, excipients, e.g. cyclodextrins, fatty acids, surfactants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Materials Engineering (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Pharmaceutical products for promoting wound healing comprise a carrier for covering wounds and injuries having an H-1 and/or H-2 receptor-blocking antihistamine as active ingredient e.g. cimetidine or ranitidine and, if desired, other pharmaceutically acceptable additives. The product is prepared by treating a solid, suitably porous, carrier with a solution containing 0.1 to 50% by weight of the active ingredient.
ES8802427A 1987-08-04 1988-08-03 Pharmaceutical products for promoting wound healing Expired ES2007544A6 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU873554A HU201683B (en) 1987-08-04 1987-08-04 Process for producing pharmaceutical compositions for promoting healing of wounds

Publications (1)

Publication Number Publication Date
ES2007544A6 true ES2007544A6 (en) 1989-06-16

Family

ID=10964527

Family Applications (1)

Application Number Title Priority Date Filing Date
ES8802427A Expired ES2007544A6 (en) 1987-08-04 1988-08-03 Pharmaceutical products for promoting wound healing

Country Status (16)

Country Link
JP (1) JPH01117828A (en)
AU (1) AU612387B2 (en)
BE (1) BE1001932A4 (en)
BG (1) BG49522A1 (en)
CH (1) CH675833A5 (en)
CS (1) CS274600B2 (en)
DD (1) DD272414A5 (en)
DE (1) DE3826419A1 (en)
ES (1) ES2007544A6 (en)
FI (1) FI883638A (en)
FR (1) FR2619011A1 (en)
GB (1) GB2207865B (en)
HU (1) HU201683B (en)
IT (1) IT1226586B (en)
NL (1) NL8801930A (en)
SE (1) SE8802805L (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU627775B2 (en) * 1988-09-20 1992-09-03 Glaxo Group Limited Pharmaceutical compositions
IT1241521B (en) * 1990-07-31 1994-01-17 Polifarma Spa THEPERAUTIC USE OF RANITIDINE IN THE TREATMENT OF INTERESTING WOUNDS SKIN AND THE UNDERLYING FABRICS
GB9102660D0 (en) * 1991-02-07 1991-03-27 Ultra Lab Ltd Wound dressing materials
DE4220736A1 (en) * 1992-06-25 1994-01-05 Puetter Medice Chem Pharm Inclusion complexes of polymerized cyclodextrins with pharmaceutically active substances
GB9424562D0 (en) 1994-12-06 1995-01-25 Giltech Ltd Product
DE9420259U1 (en) * 1994-12-17 1995-02-09 Röhm GmbH, 64293 Darmstadt Debittered ranitidine preparation
TWI221768B (en) * 1996-08-16 2004-10-11 Schering Corp Pharmaceutical composition comprising histamine H1 receptor antagonist and histamine H3 receptor antagonist providing nasal decongestant effect
US5869479A (en) * 1997-08-14 1999-02-09 Schering Corporation Treatment of upper airway allergic responses
JP2001139477A (en) * 1999-11-17 2001-05-22 Coherent Technology:Kk Tissue cell growth-promoting liquid for wounded part
DE10355085A1 (en) * 2003-11-24 2005-06-23 Schure, Frank, Dr. wound dressing
CN103816560B (en) * 2014-03-03 2015-06-24 广西南宁博恩康生物科技有限公司 Colloidal fluid used for wound restoration and preparation method thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE452109B (en) * 1973-01-29 1987-11-16 Pharmacia Ab SCIENTIFIC CLEANER EXTENDED SARYTOR
US4747845A (en) * 1983-10-17 1988-05-31 Enquay Pharmaceutical Associates Synthetic resin matrix system for the extended delivery of drugs
US4668228A (en) * 1985-03-12 1987-05-26 Johnson & Johnson Products, Inc. Debriding tape
IE58373B1 (en) * 1986-06-18 1993-09-08 Bloomfield Frederick Jacob 5-Lipoxygenase pathway inhibitors

Also Published As

Publication number Publication date
CS274600B2 (en) 1991-08-13
BE1001932A4 (en) 1990-04-17
HUT47848A (en) 1989-04-28
IT8821634A0 (en) 1988-08-03
SE8802805L (en) 1989-02-05
SE8802805D0 (en) 1988-08-03
DD272414A5 (en) 1989-10-11
AU2038788A (en) 1989-02-09
HU201683B (en) 1990-12-28
FI883638A (en) 1989-02-05
AU612387B2 (en) 1991-07-11
NL8801930A (en) 1989-03-01
GB2207865B (en) 1991-10-09
BG49522A1 (en) 1991-12-16
GB2207865A (en) 1989-02-15
CH675833A5 (en) 1990-11-15
JPH01117828A (en) 1989-05-10
GB8818575D0 (en) 1988-09-07
FR2619011A1 (en) 1989-02-10
DE3826419A1 (en) 1989-02-16
FI883638A0 (en) 1988-08-03
CS543688A2 (en) 1990-10-12
IT1226586B (en) 1991-01-24

Similar Documents

Publication Publication Date Title
HUT51269A (en) Process for producing benzimidazole derivatives and pharmaceutical compositions comprising same
SE8702907D0 (en) STABLE PHARMACEUTICAL PREPARATION CONTAINING GRANULOCYTE COLONY STIMULATING FACTOR AND PROCESS FOR PRODUCING THE SAME
TW234691B (en)
MD707C2 (en) Sulphonylurea derivatives, process of their preparation, the intermediate products for them, the herbicide and plants growing suppressing remedy on their base, weeds control process
HUT45850A (en) Insecticides comprising azolinone derivatives as active ingredient and process for producing the active ingredients
ES2007544A6 (en) Pharmaceutical products for promoting wound healing
ES8100883A1 (en) Transdermal medication system for isosorbide dinitrate
IT1170214B (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF PERIPHERAL ARTERIOPATHIES
HUT38097A (en) Process for preparing substituted benzopyrans and pharmaceutical compositions containing them as active substances
HUT57204A (en) Process for producing 4-fluoro-2-///4-methoxy-2-pyridinyl/-methyl/-sulfinyl/-1h-benzimidazol with gastric acid secration-diminishing activity and pharmaceutical compositions containing them
JO1589B1 (en) Antiviral tetrahydroimidazo(1,4)benzodiazepin-2-ones
HUT54358A (en) Process for producing substituted 1,3,5-triazinetrione derivatives and medical compositions comprising such compounds as active ingredient
HUT63151A (en) Process for producing new benzimidazole-2-sulfonamide and imidazopyuridine-2-sylfonamide derivatives, as well as pharmaceutical compositions comprising same as active ingredient
PT85766A (en) Process for the preparation of pharmaceutical compounds to wound-healing containing 1-(bicyclic heterocyclil-alkyl)-pyperidine heterocyclil derivatives and wound coating products therewith
WO1990007260A3 (en) 2,3-methanoproline
FR2567402B1 (en) NOVEL PHARMACEUTICAL AND COSMETIC COMPOSITIONS CONTAINING DIHYDROXY-1,8 PHENYL-10 ANTHRONE-9 AS ACTIVE INGREDIENT, AND PROCESS FOR PREPARING THE ACTIVE INGREDIENT
AU2626392A (en) Use of substituted pyrrolidines, some of which are known, as medicaments, new active substances and processes for their preparation
AU2626292A (en) Use of substituted tetrahydrothiophenes, some of which are known, as medicaments, new active substances and processes for their preparation
HUT49590A (en) Process for producing benzimidazole derivatives and pharmaceutical compositions comprising same as active ingredient
HUT49145A (en) Process for production of 14,15 substituated ianosterins and medical compositions containing them as active substance
JPS6431741A (en) Novel lignan, diuretic and cardiac comprising said lignan as active ingredient
JO1531B1 (en) Novel pharmacological compounds
FR2567755B1 (en) NEW ANTI-TUMOR DRUG CONTAINING TRIACETOXY-1,8,9 ANTHRACENE AS ACTIVE INGREDIENT
HUT47548A (en) Fungicides comprising dicyano-pyrazine derivatives as active ingredient and process for producing the active ingredients
JO1519B1 (en) Novel compounds (Novel deravatives of Benzimidazoles active as anti-ulcer agents).

Legal Events

Date Code Title Description
SA6 Expiration date (snapshot 920101)

Free format text: 2008-08-03

FD1A Patent lapsed

Effective date: 20001009